Minerva Neurosciences NERV
NASDAQ NERV
$3.35 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Minerva Neurosciences (NERV) EV to CFO (2017)

Updated

Minerva Neurosciences' EV to CFO was 34.36 in Q4 2017, down 34.4% from the prior quarter.

Analysis

Minerva Neurosciences (NERV) EV to CFO (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Minerva Neurosciences 158.21 Mn 158.21 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 34.36
Sep 30, 2017 52.39
API Access

Minerva Neurosciences EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=NERV&period=max&api_key=YOUR_API_KEY